Yes, and commercial experience is paid best. On 15 November 2026 Mercor listed payer and market access experts at $175 to $200 an hour, epidemiologists at $150 to $175, forecasters at $130 to $210 and disease-area clinicians at $150 to $230. Bench and computational roles ran lower: $60 to $115 for discovery and preclinical scientists at Mercor, and $45 to $120 on micro1's computational listings. Handshake AI and DataAnnotation listed related roles with "up to" ceilings. Most are part-time contract projects. A few are full-time W-2 jobs through a staffing firm. None should ever need your employer's data.
- Published pay on the day we read ran from $45 to $230 an hour across fifteen pharma and biotech listings.
- Commercial pilots (market access, forecasting, epidemiology) are short: one listing says about 10 to 20 hours over one to two weeks.
- Some roles are W-2 employment at 40 hours a week. That is a job change, not a side project.
- Your employer's confidentiality and invention agreements follow you. Unpublished compound, assay and trial data stay out of every task.
Published pay by role
These are the public listings for pharma and biotech backgrounds we read on 15 November 2026, with pay exactly as each one shows it. A range is the listing's own minimum and maximum.
| Area | Program | Listing title | Published pay |
|---|---|---|---|
| Trial endpoints and prescribing | Mercor | Disease-Area Clinician, Trial Endpoints & Prescribing | $150-$230/hr |
| Market access and pricing | Mercor | Payer & Market Access Expert, Gross-to-Net & Formulary Strategy | $175-$200/hr |
| Epidemiology | Mercor | Epidemiologist, Patient Population Sizing | $150-$175/hr |
| Commercial forecasting | Mercor | Pharma Commercial Forecasting Expert, Launch Curves | $130-$210/hr |
| Biotech investment analysis | Mercor | Biotech Investment Analyst, Drug Asset & Company Assessment | $120-$200/hr |
| Pharmaceutical R&D, senior | Mercor | Pharmaceutical R&D Domain Expert | $75-$115/hr; full-time W-2 position |
| Discovery and translational science | Mercor | Drug Discovery & Translational Science Expert | $70-$100/hr; W-2, 40 hours a week |
| Pharmacology, DMPK and toxicology | Mercor | Drug Discovery Specialist, Pharmacology & ADME/Tox | $70-$100/hr; part-time |
| Preclinical R&D | Mercor | Preclinical R&D Expert, In-house Drug Development | $60-$100/hr |
| Drug discovery task writing | Mercor | Drug Discovery Scientist | $60-$90/hr |
| Drug discovery | DataAnnotation | Drug Discovery Scientist | Up to $125+/hr, by task difficulty and specialization |
| Computational bioscience | micro1 | Computational Bioscience Expert (Python) | $60–$120/hour, paid per task |
| Computational chemistry and structural biology | micro1 | Computational Chemistry, Structural Biology & Drug Discovery Scientist (PhD) | $45-$90/hr |
| Bioinformatics | micro1 | Bioinformatics Scientist | $45-$90/hr |
| Bioinformatics and computational biology | Handshake AI | Bioinformatics/Computational Biology Expert | Up to $75/hr, depending on the project |
"Up to" is a ceiling. The rate inside a range is set per project. Academic scientists should also read AI training jobs for PhDs and postdocs, and pharmacists AI training jobs for pharmacists.
Drug discovery and preclinical scientists
Discovery work is task writing. Mercor's drug discovery listing describes "an evaluation framework for frontier AI models in drug research and development" in which the expert builds a problem with "the prompt, the data room, and the grading document". The model gets incomplete and sometimes misleading evidence and must reach a conclusion you can defend.
DataAnnotation names what models cannot yet do reliably: "SAR analysis, screening triage, DMPK and PK/PD interpretation, or a candidate-selection call". You design tasks around those calls and grade the result against a professional standard.
Preclinical roles lean on wet-lab judgment. Mercor's preclinical listing has you "Label, classify, and annotate scientific data and model outputs to improve model performance" and "Provide expert perspective on key scientific and development decisions (target/modality selection, optimization, trade-offs, risk)".
Clinical development, medical affairs and trial design
Clinical experience is used two ways. A disease-area clinician judges whether trial endpoints and prescribing assumptions are realistic; that listing showed the highest ceiling of the set. A translational scientist works earlier: Mercor's discovery and translational role covers "target identification and validation, lead optimization, biomarkers, and preclinical to clinical translation", down to a first-in-human dose rationale.
That role asks for "7+ years of dedicated industry experience in drug discovery or translational science" and a "PhD (or MD/PhD) in a relevant discipline", with a recent title at associate director, principal scientist or senior manager level or above.
Commercial roles: market access, forecasting, epidemiology
These pilots share a format. Each expert helps "Create and critique rubrics that analyze commercial drugs and drug-development programs", then applies one specialty. The market access expert will "Set and pressure-test gross-to-net and formulary-tier assumptions by drug class". The epidemiologist will "Size the patient population for a given drug or indication". The forecaster will "Build or critique a launch curve (uptake, peak share, trajectory)".
They are small by design. The market access listing gives the duration as "Approximately 10–20 hours over a 1–2 week pilot" and asks for "5+ years in market access, pricing & reimbursement, or managed markets". The investment analyst listing wants a "specialist-fund background" and has you "Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions".
Computational biology and bioinformatics
Computational roles are the most open by country. micro1's computational chemistry listing is "Remote (Worldwide)" and requires a "PhD in Computational Chemistry, Structural Biology, Biophysics, Bioinformatics, Medicinal Chemistry, Biochemistry, or a closely related field". The work is to "Design and write challenging, expert-level scientific problems in computational chemistry, structural biology, and drug discovery, with clear, verifiable solutions".
Its Python bioscience listing is "Global, fully remote" at about 15 hours a week, and it is paid by output: "Experts are paid per task that meets the project specifications". Your effective hourly rate depends on how many tasks pass review.
Handshake AI asks computational biologists to draw on "hands-on experience in genomics, NGS analysis, or computational biology", and describes the work as something "you can take on alongside your current role".
Contract or employee: the full-time W-2 roles
Most listings are contract projects. A newer kind is a job. Mercor's discovery and translational science role is "a full-time commitment of 40 hours per week" and "a W-2 employment position" with a staffing company, "with the opportunity to be placed at a leading AI Lab as part of their extended workforce". It needs you "for at least 40 hours/week during weekdays" and is for the United States.
Compare the two honestly. A W-2 role withholds tax and may carry benefits, but at $70 to $100 an hour it replaces your job, and its hourly figure is lower than the commercial pilots. A contract pilot pays more per hour for a few hours and promises nothing after. The label follows the facts: one question the IRS asks is whether the company can "control what the worker does and how the worker does his or her job" (IRS).
You cannot hold a 40-hour weekday role beside a full-time industry post. If you are between roles, consulting or recently retired, it is worth a look. If you are employed, the part-time projects are the realistic ones.
Your employer's IP and confidentiality rules
Start with your own agreements. Industry scientists sign confidentiality and invention assignment terms, and many employers require approval for outside work. Federal law defines a trade secret broadly, as "all forms and types of financial, business, scientific, technical, economic, or engineering information" that the owner keeps secret and that has value from being secret (18 U.S.C. 1839). Unpublished structures, assay results, protocols, pricing models and forecasts all fit.
So build tasks from the published literature, public databases and invented programs. The projects are designed for that: one Mercor listing has experts "assemble a data room from real, source-grounded data", and Mercor's terms say the work "will not involve access to confidential or proprietary information from any employer, client, or institution". If a task can only be answered with something you know from inside a program, do not write it.
Trial and deal knowledge carries a second risk. Securities rules treat trading on material nonpublic information "in breach of a duty of trust or confidence" as fraud (17 CFR 240.10b5-1). An investment-style assessment of a company whose unpublished data you have seen is a task to decline.
Check your employment agreement and your company's outside-activity policy before you accept, and get approval in writing where it is required. Companies that want to license their own research records do that as a company; see licensing R&D experiment records. This page is general information, not legal advice.
Tell Origin your area
The commercial pilots fill within days and the titles change with each project. Origin works with programs that hire scientists and keeps track of what is open for your modality, therapeutic area or function. For rates in other fields, see AI trainer pay rates.
Tell us your area, your years in industry and whether you want part-time or full-time work, and we'll email you what is open. It's free.
Origin Data Partners is independent of the programs on this page. A program may pay Origin when Origin introduces someone who joins it, which never changes what you are paid (how Origin is paid).
Common questions
Can I do AI training work while employed at a pharma company?
Sometimes, with approval. Check your employment agreement and outside-activity policy first, because many companies require sign-off for paid outside work. Keep every task to published or invented material. Federal law defines trade secrets broadly enough to cover unpublished assay data, structures, protocols and forecasts, and none of that belongs in a task.
Do I need a PhD for pharma and biotech AI training work?
For bench and computational roles, usually. On 15 November 2026 micro1's computational chemistry listing required a PhD, Mercor's translational role asked for a PhD or MD/PhD, and its drug discovery listing accepted a PhD or an equivalent industry track record. Commercial roles asked for experience instead, such as five or more years in market access.
Are pharma AI training roles remote and open outside the US?
Most are remote; country rules vary. On 15 November 2026 micro1's computational chemistry and bioscience listings were open worldwide. Mercor's commercial pilots asked for US-based people or deep US-market experience, its W-2 translational role was for the United States, and its pharmacology and ADME/Tox role named London and the US East Coast.
What is the difference between contract AI roles and full-time W-2 roles in pharma?
A contract role pays you as an independent contractor for approved hours or tasks, part time, with no tax withheld and no promise of more work. The W-2 roles are employment with a staffing company at 40 hours a week on weekdays, placed with an AI lab. One Mercor W-2 listing showed $70 to $100 an hour.
Will I be asked for confidential compound or trial data in AI training work?
You should not be. Mercor's terms say the work will not involve access to confidential or proprietary information from any employer, client or institution, and its discovery tasks are built from real, source-grounded public data. If a task seems to need inside knowledge of a program, decline it and tell the project team why.
Which pharma and biotech roles pay the most for AI training work?
On public listings read 15 November 2026, the commercial and clinical judgment roles: disease-area clinicians at $150 to $230 an hour, market access experts at $175 to $200, epidemiologists at $150 to $175 and commercial forecasters at $130 to $210, all at Mercor. Discovery and computational roles were listed between $45 and $120.
